The Howard University RCMI program, supported by the National Center for Research Resources of the National Institutes of Health, fulfills in part the mission of the College of Medicine to educate individuals who will serve the underserved, to engage in biomedical investigations, and to serve the needs of the underserved who suffer from diseases that disproportionately affect minority populations.
Answers to complex biomedical research questions and solutions to biomedical problems require the congruence of significant professional expertise and sophisticated, computational and material resources. The Howard University RCMI program has had a positive impact on the acquisition and development of these needed resources, including human, material, and computational.
As a consequence, Howard University biomedical scientists have made and continue to make important contributions to modern science and clinical research. Howard’s RCMI researchers devote considerable energy to addressing diseases which disproportionately affect minorities, such as asthma, hypertensive cardiovascular disease, kidney and end-stage renal diseases, cancers of the breast prostate and colon, Diabetes Mellitus, HIV/ AIDS, infant mortality, and Sickle Cell Anemia. RCMI-supported research activities will continue to impact on translation of research findings to bedside applications as well as improved clinical treatment and improved quality of life for minority populations and for members of society in general.